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Abstract 
Periostin is a matricellular protein that is involved in the pathophysiology of upper 
airway diseases [UADs, primarily allergic rhinitis and chronic rhinosinusitis (CRS)] and 
asthma. Associations of serum periostin with systemic/airway eosinophilic 
inflammation and comorbid CRS in patients with asthma have been demonstrated. 
Although serum periostin is positioned as a marker of type 2 immunity, its implication 
in comorbid UADs in patients with asthma remains unclear. We sought to investigate 
the utility of serum periostin as a diagnostic biomarker in UADs in patients with asthma. 
We prospectively enrolled 65 patients with stable asthma; 20 without UADs, 22 with 
rhinitis, 23 with CRS [13 with nasal polyps (NPs), 10 without], between July 2014 and 
December 2015. Serum periostin, eotaxin and total IgE; fractional exhaled nitric oxide 
(FeNO) and blood–sputum eosinophil levels were measured and compared between 
UAD subtypes. We evaluated the utility of each biomarker in detecting UADs, 
associations among each biomarker, severity of rhinitis and CRS as measured by the 
Lund–Mackay score (LMS) for sinus computed tomography. Serum periostin levels 
were higher in asthmatic patients with CRS (109.6 ± 47.4 ng/ml) than those without 
UADs (83.2 ± 22.9) (p = 0.04). Serum periostin levels in asthmatic patients with CRS 
with nasal polyps (NP) were significantly higher (130.0 ± 46.6) than those without NP 
(87.9 ± 37.7) (p = 0.001). Serum periostin levels were not associated with the presence 
or the severity of rhinitis. In contrast, receiver operating characteristic curve analyses 
showed moderate diagnostic accuracy for detecting CRS [area under the curve (AUC) = 
0.71, p = 0.01], and high accuracy for CRSwNP (AUC = 0.86, p = 0.0002). Furthermore, 
when comparing patients with comorbid CRSwNP to those with comorbid CRSsNP, 
serum periostin was found to be the sole biomarker for detecting the presence of NP. 
Serum periostin was also the sole biomarker which significantly correlated with LMS in 
patients with CRS (r = 0.44, p = 0.04). We concluded that serum periostin is useful for 
detecting CRSwNP and reflecting radiological CRS severity in patients with asthma. 
 
